Bryan Johnson· Author
A new longevity stem cell therapy in monkeys showed an estimated 3–5 yrs of biological age reversal, across 54% of tissues.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
A new longevity stem cell therapy in monkeys showed an estimated 3–5 yrs of biological age reversal, across 54% of tissues.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
When injected into cynomolgus monkeys (2 million cells/kg) across various age groups, SRCs demonstrated significant rejuvenation, reversing brain atrophy, blood senescence, inflammation, and oxidative stress.
FOXO3-enhanced senescence resistant MPCs (SRCs) consistently outperformed wild-type MPCs, producing systemic rejuvenation across brain, blood, and organs.
Over 44 weeks, the monkeys that received these cells experienced an age reversal of 3 to 5 years and also rejuvenated organs, improved brain health, stronger immune function, and increased reproductive health.
The wild thing about this is they had a measured age reversal in over 54% of all tissues. It didn't just slow their aging, it actually made them younger.
Old monkeys injected with special stress-resistant human progenitor cells had improved cognitive function, bone density, less reproductive system decline, and slower rates of aging in multiple tissues!
Scientists demonstrated that senescence resistant mesenchymal progenitor cells (SRCs), engineered with the longevity gene FOXO3, can not only halt aging but partially reverse it in aged macaques.